Overview ImpediMed received FDA 510(k) clearance for sarcopenia risk assessment using its SOZO Digital Health Platform. SOZO becomes the only FDA-cleared bioimpedance spectroscopy (BIS) solution for c...
Conversations Shaping Tomorrow's Healthcare
Overview ImpediMed received FDA 510(k) clearance for sarcopenia risk assessment using its SOZO Digital Health Platform. SOZO becomes the only FDA-cleared bioimpedance spectroscopy (BIS) solution for c...